IMC Chicago’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46M Buy
30,500
+1,800
+6% +$353K ﹤0.01% 1894
2026
Q1
$5.62M Sell
28,700
-2,500
-8% -$486K ﹤0.01% 1691
2025
Q4
$5.41M Buy
31,200
+10,500
+51% +$1.91M ﹤0.01% 1680
2025
Q3
$3.95M Buy
20,700
+5,700
+38% +$1.01M ﹤0.01% 1741
2025
Q2
$2.69M Sell
15,000
-2,800
-16% -$486K ﹤0.01% 1799
2025
Q1
$3.01M Buy
+17,800
New +$2.92M ﹤0.01% 1526
2024
Q4
Sell
-13,600
Closed -$2.11M 3186
2024
Q3
$2.11M Buy
+13,600
New +$2.03M ﹤0.01% 1629

Other funds holding DGX

IMC Chicago's DGX Position: Q2 2026 in Review

IMC Chicago sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 5,227 shares — an estimated $1.03M sold.

IMC Chicago first reported a position in DGX in Q1 2026 and held it in 1 quarter. The position peaked at $1.02M in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • IMC Chicago reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 5,227 Quest Diagnostics shares in Q2 2026, an estimated $1.03M.
  • IMC Chicago first reported a position in Quest Diagnostics in Q1 2026 and held it in 1 quarter.
  • IMC Chicago's Quest Diagnostics position peaked at $1.02M in Q1 2026.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.